Larimar Therapeutics, Inc. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Larimar Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • Larimar Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -35.9 %, a 10.1% decline year-over-year.
  • Larimar Therapeutics, Inc. annual Return On Equity for 2023 was -38.8 %, a 7.55% increase from 2022.
  • Larimar Therapeutics, Inc. annual Return On Equity for 2022 was -42 %, a 41.4% increase from 2021.
  • Larimar Therapeutics, Inc. annual Return On Equity for 2021 was -71.6 %, a 29.5% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -38.8 +3.17 +7.55% Jan 1, 2023 Dec 31, 2023
2022 -42 +29.6 +41.4% Jan 1, 2022 Dec 31, 2022
2021 -71.6 -16.3 -29.5% Jan 1, 2021 Dec 31, 2021
2020 -55.3 +3.06K +98.2% Jan 1, 2020 Dec 31, 2020
2019 -3.12K -3.01K -2741% Jan 1, 2019 Dec 31, 2019
2018 -110 -54.6 -99.1% Jan 1, 2018 Dec 31, 2018
2017 -55.1 -12.9 -30.5% Jan 1, 2017 Dec 31, 2017
2016 -42.2 -4.43 -11.7% Jan 1, 2016 Dec 31, 2016
2015 -37.8 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.